Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05304299 |
Other study ID # |
IRB-19-024 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
March 10, 2020 |
Est. completion date |
December 31, 2021 |
Study information
Verified date |
March 2022 |
Source |
Chung Shan Medical University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This study will investigate the effects of lowering intraocular pressure by oral intake of
Cordyceps cicadae mycelia, to provide evidence-based data for high intraocular pressure
relief.
Description:
Study purpose This study investigated the effeicacy of oral Cordyceps cicadae mycelia for the
relief of high intraocular pressure.
Subjects
1. The total recruitment of subjects is 60 people, aged between 20 to 75 years.
2. Subjects with intraocular pressure more than or equal to 21 mmHg are included,
irrespective of whether on us of Taflotan (saflutan).
Methods
1. Informed consents will be obtained from subjects first. The subjects with pre-test
intraocular pressure over or equal 21 mm Hg are advised to orally take two capsules
containing a total of 500 mg of Cordyceps cicadae mycelia. After 90 minutes, the subjects are
evaluated for intraocular pressure.
The pre-test and and post-intake intraocualr pressure and blood pressure data will be
compared by paired t test for significant differences if any.